So-Young Intl Stock Price, News & Analysis

So-Young International Inc. (NASDAQ: SY) will release its financial results for Q3 2022 on November 18, 2022, prior to U.S. market opening. Following this, an earnings conference call is scheduled for 7:00 AM ET the same day, with dial-in options for international, U.S., and China callers. The call will be accessible via a live and archived webcast on the company's investor relations website. So-Young continues to serve as a leading social community in China for the medical aesthetics sector, fostering a trustworthy platform for users.

So-Young International Inc. (Nasdaq: SY) announced the immediate withdrawal of its non-binding going private proposal by Chairman and CEO Mr. Xing Jin. This decision follows a review of current market conditions, leading the board to dissolve the special committee overseeing the proposal. So-Young remains positioned as a leading social community in China's medical aesthetics industry, emphasizing its trusted platform and extensive service provider network.

So-Young International Inc. (SY) reported its second quarter financial results for 2022, showing total revenues of RMB309.1 million (US$46.1 million), down 31.6% year-over-year. The company posted a net loss of RMB32.3 million (US$4.8 million), a decline from a net income of RMB57.6 million in Q2 2021. Average mobile monthly active users fell to 3.5 million from 10 million a year ago. Despite challenges, the number of paying medical service providers grew by 17.1% to 5,735. For Q3 2022, So-Young anticipates revenues between RMB310 million and RMB330 million, indicating a continued decline from the previous year.

So-Young International Inc. (NASDAQ: SY) will report its financial results for the second quarter ended June 30, 2022, before U.S. markets open on August 16, 2022. An earnings conference call will follow on the same day at 7:30 AM U.S. Eastern Time. Due to COVID-19, participants must preregister online to receive dial-in details. So-Young is a leading platform in China's medical aesthetics industry, providing trusted information and community engagement for consumers and service providers.

So-Young International Inc. (Nasdaq: SY) announced it received a notification from Nasdaq regarding non-compliance with minimum bid price requirements, as its ADSs closed below $1.00 for 30 consecutive days. The company has until January 11, 2023, to regain compliance. If the ADS price reaches $1.00 for at least ten consecutive business days, Nasdaq will confirm compliance. The notification does not affect business operations, and So-Young plans to take measures to regain compliance within the grace period.

So-Young International (SY) reported unaudited financial results for Q1 2022, with total revenues of RMB300.3 million, down 16.5% year-over-year. The net loss widened to RMB66.8 million from RMB45.0 million in Q1 2021. Average monthly active users decreased significantly to 4.4 million from 8.4 million. Despite challenges from COVID-19, the company saw a 11.7% increase in paying medical service providers, totaling 5,254. The decline in revenue stemmed largely from reduced average revenue per provider, prompting a cautious outlook with no revenue guidance for Q2 2022 amid ongoing uncertainties.

So-Young International Inc. (NASDAQ: SY) will report its financial results for the first quarter ending March 31, 2022, on May 23, 2022, before U.S. markets open. As the largest social community in China focused on medical aesthetics, So-Young connects consumers and service providers, driving engagement and trust within the sector. The earnings release will be available on the Company's investor relations webpage, highlighting its position to expand in both medical aesthetics and the broader healthcare service market.

So-Young International Inc. (Nasdaq: SY) announced updates regarding its status under the Holding Foreign Companies Accountable Act (HFCAA) after being identified by the SEC on May 9, 2022. The identification stems from the use of a public accounting firm whose working papers cannot be fully inspected by the PCAOB for the fiscal year ending December 31, 2021. If identified for three consecutive years, So-Young's shares could be prohibited from trading in the U.S. The Company is actively seeking solutions to protect stakeholder interests and intends to comply with all applicable regulations to maintain its Nasdaq listing.

So-Young International Inc. (Nasdaq: SY), a leading social community in China's medical aesthetics sector, has filed its annual report on Form 20-F for the fiscal year ending December 31, 2021, with the SEC on May 2, 2022. The report is accessible on the Company's investor relations website. Shareholders can request a hard copy of the report, including audited financial statements, at no charge. So-Young aims to leverage its brand and user trust to expand in the medical aesthetics industry and the broader healthcare market.